Table 3.
Net annualized patient out-of-pocket costs for medical services and prescription drugs by phase of care and stage at diagnosis, SEER-Medicare 2007-2013a,b,c
| Service type and cancer site | Phase of care |
|||||
|---|---|---|---|---|---|---|
| Initial phase |
End-of-life cancer death |
|||||
| Localized | Regional | Distant | Localized | Regional | Distant | |
| Medical services (Medicare Parts A/B) | ||||||
| Bladder | $1244 | $2956 | $3952 | $2634 | $3564 | $4810 |
| Breast | $2053 | $3108 | $3711 | $2479 | $2893 | $3677 |
| Cervix uteri | $2221 | $3572 | $4100 | $2770 | $3102 | $3690 |
| Colorectal | $1755 | $3283 | $5953 | $3000 | $3616 | $4932 |
| Esophagus | $3379 | $5092 | $4878 | $3914 | $4467 | $5002 |
| Kidney | $1508 | $1993 | $3140 | $3007 | $3449 | $4006 |
| Liver | $2742 | $2829 | $3714 | $2647 | $2708 | $3631 |
| Lung | $2238 | $3406 | $4567 | $2840 | $3605 | $4756 |
| NSCLC | $2207 | $3313 | $4542 | $2816 | $3540 | $4755 |
| SCLC | $3514 | $4559 | $4745 | $3274 | $4068 | $4761 |
| Melanoma | $706 | $1636 | $2719 | $2498 | $2892 | $4575 |
| Oral cavity or pharynx | $1727 | $4044 | $4645 | $3178 | $4154 | $4476 |
| Ovary | $1891 | $3022 | $3565 | $2965 | $3098 | $4086 |
| Pancreas | $3133 | $4858 | $4646 | $3519 | $4256 | $4571 |
| Prostated | $1834 | $1826 | $2800 | $3047 | ||
| Stomach | $2358 | $4260 | $4731 | $3289 | $4010 | $4882 |
| Thyroid | $1149 | $1644 | $2520 | $3094 | $3491 | $3480 |
| Uterus | $1575 | $2769 | $3430 | $2858 | $3278 | $3706 |
| All sites combined | $1694 | $3194 | $3540 | $2868 | $3604 | $4526 |
| Prescription drugs covered through pharmacy benefit (Medicare part D) | ||||||
| Bladder | $154 | $146 | $195 | $248 | $143 | $226 |
| Breast | $214 | $251 | $280 | $302 | $279 | $271 |
| Cervix uteri | −$6 | −$28 | $92 | −$53 | $44 | $32 |
| Colorectal | $64 | $48 | $115 | $94 | $94 | $102 |
| Esophagus | $415 | $235 | $444 | $193 | $169 | $341 |
| Kidney | $224 | $302 | $1713 | $627 | $979 | $1326 |
| Liver | $490 | $754 | $1435 | $591 | $1008 | $1336 |
| Lung | $325 | $408 | $787 | $484 | $513 | $618 |
| NSCLC | $324 | $417 | $851 | $499 | $550 | $687 |
| SCLC | $360 | $305 | $346 | $206 | $251 | $290 |
| Melanoma | $125 | $236 | $434 | $445 | $350 | $438 |
| Oral cavity or pharynx | $99 | $197 | $198 | $350 | $136 | $211 |
| Ovary | −$5 | −$11 | $221 | $289 | $50 | $145 |
| Pancreas | $449 | $796 | $1308 | $521 | $897 | $1057 |
| Prostated | $85 | $290 | $507 | $640 | ||
| Stomach | $291 | $221 | $596 | $120 | $134 | $268 |
| Thyroid | $222 | $232 | $316 | $745 | $434 | $218 |
| Uterus | $24 | $55 | $87 | $140 | $126 | $195 |
| All sites combined | $180 | $224 | $833 | $342 | $373 | $613 |
Includes patients diagnosed with invasive cancers with information about stage at diagnosis; patients diagnosed with in-situ disease or missing information about stage were excluded from stage-specific analyses. NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results Program.
Costs associated with cancer are estimated as the difference between cancer cases and matched controls. All estimates in 2019 US dollars.
Out-of-pocket costs estimated from patient responsibility for medical services (including infusion drugs) under Medicare Parts A/B claims. Out-of-pocket costs for oral prescription drugs estimated directly from Medicare Part D claims.
Prostate cancer stage reported as localized or regional during some years of study.